Dxcover
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Suite Rc534 Royal College Building 204 G...Website
www.dxcover.comRevenue
$10.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Dxcover
Headquartered in Scotland, Dxcover is a clinical-stage diagnostics company developing spectroscopic liquid biopsy technology for early detection of multiple cancers. The company was established in 2019.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dxcover your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Dxcover is spiking on competitors!
Funding: Get notified immidiatlly once Dxcover has new funding data
Product Launch: Get notified when Dxcover launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Dxcover
Website visits: Recent activity has been detected on your website
Check if Dxcover has recently received funding, and reach out quickly before it becomes old news!
Dxcover, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Dxcover recently announced quarterly report
Click to see if Dxcover had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Dxcover as Masked Content
Find 3 more new buyers
Compare Similar Companies to Dxcover
Compare insights from companies similar to Dxcover, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Dxcover
$10.5M
11-50
Private
$11.9M
2019
N/A
Company Profile Activity
Activity Insights
Dxcover is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Dxcover is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Dxcover.
Dxcover financials insights
Gather financial insights about Dxcover, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$9.3M
Grant
$2.7M
Dxcover Tech Stack
A closer look at the technologies used by Dxcover
Most Recent Scoops
Facilities Relocation / Expansion
Facilities Relocation/Expansion, Business Development, Real Estate, Office Operations, Operations
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Award
Award, Healthcare Technology, Radiology
Funding
Funding
Promotion
Executive Move
Dxcover News & Media
Dxcover Launches US Operations to Commercialize Its AI-Powered Multiomic Cancer Detection Test
NASHVILLE, Tenn.--(BUSINESS WIRE)-- #Dxcover--Dxcover, a UK-based company improving early cancer detection with its AI-powered multiomic technology, announced today the launch of its United States headquarters in Nashville, Tennessee. The move reflects Dxcover's commitment to commercializing its PANAROMIC™ cancer test in the world's biggest life sciences market. Dxcover's innovative Drop. Dry. Detect. ™ approach offers a cost-effective, high-throughput, non-invasive cancer screening platform. ThDxcover announces global presentation of first real-world evidence demonstrating that increased tumor size is associated with higher mortality in patients with brain cancer
GLASGOW, Scotland--(BUSINESS WIRE)-- #AACR2025--Dxcover announces global presentation of first real-world evidence demonstrating increased tumor size linked with higher brain cancer mortality.Dxcover Raises New Funding Round To Expand Commerical Presence
Dxcover, a clinical-stage diagnostics company advancing its multiomic spectral analysis (MOSA-Dx) for early detection of solid tumor cancers, announced its next key stage of growth with the closing of significant funding to advance innovation and expand its commercial presence.Dxcover Raises Funding
Dxcover, a Glasgow, Scotland, UK-based clinical-stage diagnostics company, raised an undisclosed amount in funding. Backers included existing investors, as well as new investors, Macmillan Cancer Support and Maven Capital Partners. This brought the total funding raised to $21.4M since spinning out from the University of Strathclyde in 2019. The company intends to use the funds […] The post Dxcover Raises Funding appeared first on FinSMEs.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dxcover
Sign Up For FreeTo access detailed company insights
Headquartered in Scotland, Dxcover is a clinical-stage diagnostics company developing spectroscopic liquid biopsy technology for early detection of multiple cancers. The company was established in 2019.... Read More
